Page 49 - Drug Pricing Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Department of Health and Human Services (HHS) Secretary Xavier Becerra testified on May 12 before the House Energy and Commerce Health Subcommittee on President Joe Biden’s fiscal year (FY) 2022 HHS discretionary budget request, which proposes $131.7 billion in funding, an increase of $25 billion over FY 2021 [refer to Throughout the hearing, subcommittee members raised a number of issues in their questions and comments, including the COVID-19 response and preparing for future public health crises, caring for unaccompanied children at the southern border, medical research, access to afford...

To embed, copy and paste the code into your website or blog: Welcome to the first issue of the Latham & Watkins Drug Pricing Digest. Here, Latham’s government price reporting team provides a digest of recent developments, as reported in the trade press or published directly by government bodies, which we intend to distribute at the start of every second week. In this digest, we cover general developments, followed by sections focusing on the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments. Please see full Publication below for more i...

University of Illinois at Chicago According to a new study published in the journal Research in Social and Administrative Pharmacy, hospitals that participate in the 340B Drug Pricing Program provide more medication access services — which are services that help remove barriers to accessing necessary medications — than comparably sized non-340B hospitals. The University of Illinois Chicago researchers who conducted the study, which included a survey of available services sent to a nationally representative sample of hospitals across the U.S., suggest that 340B participating hospitals may ...

Share this article Share this article CHICAGO, April 20, 2021 /PRNewswire/ -- Innovative tech company Kalderos today released its 2021 annual report. The report highlights the company's perspective on key challenges in the drug channel, leverages unique data to provide insights into drug discount programs, and advocates for a new model that utilizes platform technology to make drugs more affordable for patients. "As we dive deeper into 2021, we see big developments on the horizon for the business of healthcare," said Kalderos CEO Jeremy Docken. "Industry trends are driving change and so is t...

The ACCC 47 th Annual Meeting & Cancer Center Business Summit (AMCCBS) took place virtually, March 1-5. The Cancer Center Business Summit was co-founded in 2007 by Foley & Lardner LLP and CCBD Group as an opportunity for members of the community oncology c-suite, providers, vendors, payors, and others involved in the business of oncology to share best practices, learn about newest technologies, trends, and legal and business updates in the industry, and to strategize to position themselves for success. In 2017, the Summit joined forces with the Association of Community Cancer Centers (ACCC), ...